Digoxin Use Associated With Higher Risk of Death for Heart Failure Patients, Kaiser Permanente Study

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Digoxin, a drug commonly used to treat heart conditions, was associated with a 72 percent higher rate of death among adults with newly diagnosed systolic heart failure, according to a Kaiser Permanente study that appears in the current online issue of Circulation: Cardiovascular Quality and Outcomes.

1Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC